Skip to content

A study on the development of medication compliance plans for pregnant women with different types of gestational hypertension based on the Green Model

A study on the development of medication compliance plans for pregnant women with different types of gestational hypertension based on the Green Model

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500113248
Enrollment
Unknown
Registered
2025-11-26
Start date
2025-12-01
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertensive disorder complicating pregnancy

Interventions

Trail group:None

Sponsors

Lianyungang Maternal and Child Health Care Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Pregnant women with gestational hypertension who meet the diagnostic criteria, including gestational hypertension, preeclampsia, chronic hypertension with pregnancy, etc. (refer to the "Chinese Guidelines for the Diagnosis and Treatment of Hypertensive Disorders in Pregnancy" 2020 edition); 2. Gestational age between 20 and 34 weeks and have established a medical record for prenatal check-ups at the research hospital; 3. Clearly advised by doctors to receive drug treatment (such as low-dose aspirin, labetalol, etc.) and have started taking the medication; 4. Have a certain self-management ability and can independently or with the assistance of family members complete questionnaires and intervention activities; 5. Own a smart phone and know how to use WeChat, and can participate in online follow-ups and check-ins; 6. Voluntarily participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Individuals with severe underlying diseases (such as severe heart, liver, or kidney dysfunction) or mental disorders that affect communication and behavior execution; 2. Those with other high-risk complications during pregnancy, such as gestational diabetes, placental abruption, preterm labor, etc., which seriously interfere with the intervention process; 3. Those who have not used the prescribed antihypertensive or preventive medications as advised by the doctor, or those who refuse to take the medications; 4. Those with a gestational age too small (34 weeks), which is not conducive to the implementation of the intervention period; 5. Those participating in other intervention research projects; 6. Those with incomplete data or unable to complete the follow-up and assessment procedures.

Design outcomes

Primary

MeasureTime frame
medication compliance;

Secondary

MeasureTime frame
perceived social support scale;health belief;

Countries

China

Contacts

Public ContactWang Liping

Lianyungang Municipal Health Commission

19901578227@163.com+86 199 0157 8227

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026